XML 74 R61.htm IDEA: XBRL DOCUMENT v3.21.1
Summary of Signficant Accounting Policies (Details) - USD ($)
$ in Millions
 12 Months Ended
Feb. 26, 2021
Feb. 28, 2020
Feb. 22, 2019
Feb. 23, 2018
Accounting Policies [Line Items]        
Restricted Cash   $ 6.1 $ 3.5 $ 2.5
Fiscal Year [Abstract]        
Number of weeks in quarter P13W P14W P13W  
Number of weeks in fiscal year P52W P53W P52W  
Workers Compensation [Abstract]        
Workers' Compensation Liability, net of associated receivables $ 8.0 $ 10.1    
Workers' Compensation Liability, Current 2.1 2.7    
Workers' Compensation Liability, Noncurrent 10.5 11.6    
Workers' Compensation Liability 12.6 14.3    
Worker's Compensation Liability, associated receivable 4.6 4.2    
Product Liability [Abstract]        
Loss Contingency Accrual, Product Liability, Net 2.0 2.8    
Loss Contingency Accrual, Product Liability, associated receivables 0.7 1.3    
Loss Contingency Accrual, Product Liability, Gross 2.7 4.1    
Employee medical, dental and short term liability [Abstract]        
Liability for Claims and Claims Adjustment Expense 0.0      
Product Warranties [Abstract]        
Product Warranty Accrual, Noncurrent 11.4 14.3    
Environmental Matters [Abstract]        
Accrual for Environmental Loss Contingencies, Gross 2.7 2.9    
Accrual for Environmental Loss Contingencies, Gross $ 2.8 $ 3.1    
Accrual for Environmental Loss Contingencies, Discount Rate 3.00% 2.50%    
Research and Development Expense [Abstract]        
Research and Development Expense $ 48.1 $ 50.6 $ 53.7  
Financial Instruments [Abstract]        
Debt and Lease Obligation 483.9 484.3    
Balance Sheet Related Disclosures [Abstract]        
Foreign Currency Contract, Asset, Fair Value Disclosure 1.1 1.2    
Foreign Currency Contracts, Liability, Fair Value Disclosure (0.8) (0.5)    
Derivative, Fair Value, Net [1] 0.3 0.7    
Derivative, Notional Amount 58.8 117.6    
Income Statement Related Disclosures [Abstract]        
Cost of sales 1,822.8 2,508.5 2,355.3  
Operating expenses 684.2 958.2 904.3  
Other income (expense), net (8.6) (10.1) (14.9)  
Derivative Instruments, Gain (Loss) Recognized in Income, Net (0.8) (5.4) (4.5)  
Fair Value, Recurring [Member]        
Accounting Policies [Line Items]        
Restricted Cash 5.8 6.1    
Balance Sheet Related Disclosures [Abstract]        
Foreign Currency Contracts, Liability, Fair Value Disclosure (0.8) (0.5)    
Fair Value, Inputs, Level 1 [Member] | Fair Value, Recurring [Member]        
Accounting Policies [Line Items]        
Restricted Cash 5.8 6.1    
Balance Sheet Related Disclosures [Abstract]        
Foreign Currency Contracts, Liability, Fair Value Disclosure 0.0 0.0    
Forward Contracts [Member]        
Income Statement Related Disclosures [Abstract]        
Cost of sales 0.1 1.8 1.5  
Operating expenses (0.1) 0.5 0.3  
Other income (expense), net $ 0.8 3.1 $ 2.7  
Minimum [Member]        
Organization, Consolidation and Presentation of Financial Statements [Abstract]        
Equity Method Investment, Ownership Percentage 20.00%      
Product Warranties [Abstract]        
Standard Product Warranty, Term 3 years      
Maximum [Member]        
Organization, Consolidation and Presentation of Financial Statements [Abstract]        
Equity Method Investment, Ownership Percentage 50.00%      
Product Warranties [Abstract]        
Standard Product Warranty Description lifetime      
Estimate of Fair Value, Fair Value Disclosure [Member]        
Financial Instruments [Abstract]        
Long-term Debt, Fair Value $ 568.1 560.0    
Other Current Liabilities [Member]        
Product Liability [Abstract]        
Loss Contingency Accrual 0.5 0.6    
Other Noncurrent Liabilities [Member]        
Product Liability [Abstract]        
Loss Contingency Accrual $ 2.2 $ 3.5    
[1] The notional amounts of the outstanding foreign exchange forward contracts were $58.8 as of February 26, 2021 and $117.6 as of February 28, 2020.